A safety and efficacy Sstudy of eltrombopag in subjects with AML

Autores
Categoría Estudio primario
Registro de estudiosClinicalTrials.gov
Año 2013

Este artículo no está incluido en ninguna revisión sistemática

Cargando información sobre las referencias
The purpose of this randomized, blinded, placebo-controlled study was to provide clinical safety and exploratory efficacy data on the use of Eltrombopag in adult subjects with Acute Myeloid Leukemia (AML) receiving standard induction chemotherapy with daunorubicin plus cytarabine. A minimum of 120 evaluable subjects newly diagnosed with AML was stratified by antecedent malignant hematologic disorder and age.
Epistemonikos ID: 5ae7a3cc0604b0a7da185d51ddb4ab54cc9c26a8
First added on: Jan 21, 2022